Clinical trials

The initial pilot study into the use of Fenzian in asthma was published in the European Respiratory Journal in 2009.  The encouraging results triggered the FAMOUS asthma multicentre study at Johns Hopkins, Duke University, Addenbrookes, London Chest, University of Cape Town Lung Institute and in California. This is expected to be completed by June 2012.  A further asthma pilot study into use of Fenzian in severe, unstable asthmatics was completed in August 2011 with encouraging provisional results.

From the initial audit results, through scientific studies, pilot studies and clinical trials Fenzian has shown already most encouraging outcomes. There have been no negative outcomes even though there is wide variation in the studies undertaken.

See details of our published results.